UAP1L1 Activators
UAP1L1 Activators function through various biochemical mechanisms to enhance the enzyme's activity in cellular metabolism, particularly in processes involving the synthesis of UDP-N-acetylglucosamine. Certain activators target the protein kinase A (PKA) signaling cascade by elevating intracellular cyclic AMP (cAMP) levels, which leads to enhanced phosphorylation of target proteins that could include UAP1L1, thus potentially increasing its functional activity. Other compounds inhibit the breakdown of cAMP, thereby sustaining PKA activation and phosphorylation pathways that indirectly influence UAP1L1 activity. In response to disruptions in the Golgi apparatus and the resulting impact on glycosylation, there is a conceivable increase in UAP1L1 activity as the cell attempts to compensate for glycosylation deficits. Similarly, inhibition of protein dephosphorylation can result in an indirect upregulation of UAP1L1 through sustained phosphorylation states.
Additional activators operate by modulating cellular stress pathways, energy metabolism, and nucleotide sugar metabolism. Inhibition of protein synthesis and subsequent activation of stress-activated protein kinase pathways may lead to an indirect upregulation of UAP1L1 in an attempt to adjust glycosylation in response to cellular stress. Activators which enhance AMP-activated protein kinase activity reflect the cell's need for efficient energy utilization, indirectly affecting UAP1L1's role in metabolic pathways. Moreover, compounds that influence the availability of substrates or intermediates in glycosylation pathways may also elevate UAP1L1 activity. For instance, the provision of amino sugars for the biosynthesis of glycosaminoglycans can increase the availability of substrates necessary for UAP1L1's enzymatic reactions, thereby stimulating its activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Phosphodiesterase inhibitor that prevents the breakdown of cAMP, resulting in sustained PKA activation. This can indirectly increase the activity of UAP1L1 through enhanced phosphorylation processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi apparatus structure and function, affecting glycosylation processes. UAP1L1, being involved in UDP-N-acetylglucosamine metabolism, may be indirectly activated as cells attempt to compensate for glycosylation deficits. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of various proteins. This can indirectly upregulate UAP1L1 activity by decreasing its dephosphorylation rate. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Protein synthesis inhibitor that activates stress-activated protein kinase pathways such as JNK. As a response to stress, UAP1L1 activity may be indirectly upregulated to modulate glycosylation in stress conditions. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AMP-activated protein kinase (AMPK) activator, which can enhance cellular energy metabolism. UAP1L1, being part of metabolic processes, might be activated in response to the cellular need for efficient energy use. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
Essential coenzyme in redox reactions, also involved in ADP-ribosylation and sirtuin activation, which may affect protein metabolism and indirectly increase UAP1L1 activity due to its role in nucleotide sugar metabolism. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibitor of glycogen synthase kinase 3 (GSK-3), which may indirectly increase UAP1L1 activity through altered signaling pathways involved in cell growth and metabolism. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Increases glucose uptake and metabolism, indirectly affecting UAP1L1 activity due to its role in UDP-N-acetylglucosamine synthesis, which is required for glycosylation. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Activates AMPK, potentially increasing cellular demand for efficient energy metabolism and indirectly activating UAP1L1 due to its involvement in metabolic pathways. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glucose analog that inhibits glycolysis, potentially upregulating UAP1L1 activity as a compensatory mechanism in nucleotide sugar metabolism. | ||||||